Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ejca.2020.05.017 http://scihub22266oqcxt.onion/10.1016/j.ejca.2020.05.017 32534244!7261437!32534244     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Cancer 2020 ; 135 (ä): 47-50 Nephropedia Template TP {{tp|p=32534244|t=2020. Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic |pdf=|usr=}}{{32534244}} gab.com Text Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic JO: Eur J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32534244 #FOAvip The novel coronavirus (CoV) pandemic is a serious threat for patients with cancer, who have an immunocompromised status and are considered at high risk of infections. Data on the novel CoV respiratory disease (coronavirus disease 2019 [COVID-19]) in patients with cancer are still limited. Unlike other common viruses, CoVs have not been shown to cause a more severe disease in immunocompromised subjects. Along with direct viral pathogenicity, in some individuals, CoV infection triggers an uncontrolled aberrant inflammatory response, leading to lung tissue damage. In patients with cancer treated with immunotherapy (e.g. immune checkpoint inhibitors), COVID-19 may therefore represent a serious threat. After a thorough review of the literature on CoV pathogenesis and cancer, we selected several shared features to define which patients can be considered at higher risk of COVID-19. We combined these clinical and laboratory variables, with the aim of developing a score to weight the risk of COVID-19 in patients with cancer. Twit Text FOAVip Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic ????Eur J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=32534244 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32534244 #FOAvip English Wikipedia <ref>{{Cite pmid|32534244}}</ref> Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic #MMPMID32534244 Indini A; Rijavec E; Ghidini M; Cattaneo M; Grossi F Eur J Cancer 2020[Aug]; 135 (ä): 47-50 PMID32534244show ga The novel coronavirus (CoV) pandemic is a serious threat for patients with cancer, who have an immunocompromised status and are considered at high risk of infections. Data on the novel CoV respiratory disease (coronavirus disease 2019 [COVID-19]) in patients with cancer are still limited. Unlike other common viruses, CoVs have not been shown to cause a more severe disease in immunocompromised subjects. Along with direct viral pathogenicity, in some individuals, CoV infection triggers an uncontrolled aberrant inflammatory response, leading to lung tissue damage. In patients with cancer treated with immunotherapy (e.g. immune checkpoint inhibitors), COVID-19 may therefore represent a serious threat. After a thorough review of the literature on CoV pathogenesis and cancer, we selected several shared features to define which patients can be considered at higher risk of COVID-19. We combined these clinical and laboratory variables, with the aim of developing a score to weight the risk of COVID-19 in patients with cancer. |Age Factors[MESH] |Betacoronavirus/immunology/*pathogenicity[MESH] |COVID-19[MESH] |Comorbidity[MESH] |Coronavirus Infections/*epidemiology/immunology/virology[MESH] |Humans[MESH] |Immunocompromised Host/*immunology[MESH] |Immunotherapy/*adverse effects[MESH] |Neoplasms/complications/epidemiology/*immunology/therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/*epidemiology/immunology/virology[MESH] |Risk Assessment[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]Developing a risk assessment score for patients with cancer during the(epmc).pdf DeepDyve Pubget Overpricing